{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:48:38Z","timestamp":1767919718510,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Support Program for Oncological Care","award":["NUP-25000.023997.2018\/34"],"award-info":[{"award-number":["NUP-25000.023997.2018\/34"]}]},{"name":"National Support Program for Oncological Care","award":["NUP 25000.192948\/2019-21"],"award-info":[{"award-number":["NUP 25000.192948\/2019-21"]}]},{"name":"National Support Program for Oncological Care","award":["NUP-25000.023997.2018\/34"],"award-info":[{"award-number":["NUP-25000.023997.2018\/34"]}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/12283-6"],"award-info":[{"award-number":["2022\/12283-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/16187-1"],"award-info":[{"award-number":["2022\/16187-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/12283-6"],"award-info":[{"award-number":["2022\/12283-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-grade cervical intraepithelial lesions (CIN 2\/3) are critical targets for early detection in cervical cancer prevention. MicroRNAs are stable, tissue-specific molecules involved in cancer-related pathways and can be detected in minimally invasive samples, making them suitable for use in the context of liquid biopsies. This exploratory study aimed to identify differentially expressed microRNAs in paired liquid-based cytology (LBC) and plasma samples from women with CIN 2\/3, and to evaluate miR-339-3p as a potential biomarker. Samples from 70 women (35 cases with histologically confirmed high-grade lesions and 35 age-matched controls with normal cytology and negative HPV tests) were analyzed using a commercial microRNA panel on the NanoString platform. We identified 57 dysregulated microRNAs in LBC samples and 33 in plasma, with four shared between both matrix types. Among these, miR-339-3p was the only one consistently upregulated and significantly associated with case status. In LBC samples, the area under the curve was 0.65; in plasma, 0.64. Pathway analysis suggested its involvement in apoptosis-related pathways, including PI3K-Akt and p53. Moreover, this study highlights the value of integrating microRNA profiling across local and systemic samples to advance biomarker discovery in cervical cancer.<\/jats:p>","DOI":"10.1038\/s41598-025-30514-3","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:25:21Z","timestamp":1764710721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring shared microRNA profiles in liquid-based cytology and plasma as biomarkers of high-grade intraepithelial lesions"],"prefix":"10.1038","volume":"16","author":[{"given":"St\u00e9phanie","family":"Calfa","sequence":"first","affiliation":[]},{"given":"Ana Julia Aguiar","family":"de Freitas","sequence":"additional","affiliation":[]},{"given":"Rhafaela Lima","family":"Causin","sequence":"additional","affiliation":[]},{"given":"Welinton","family":"Hirai","sequence":"additional","affiliation":[]},{"given":"J\u00falio C\u00e9sar","family":"Possati-Resende","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"dos Reis","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia Maria Chiquitelli","family":"Marques","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"30514_CR1","unstructured":"Global Cancer Statistics. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. (2020). https:\/\/pubmed.ncbi.nlm.nih.gov\/33538338\/"},{"key":"30514_CR2","unstructured":"Instituto Nacional de C\u00e2ncer. Estimativa 2023: incid\u00eancia de c\u00e2ncer no Brasil. Rio de Janeiro: INCA (2022)."},{"key":"30514_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie, E. J., Einstein, M. H., Franceschi, S. & Kitchener, H. C. Human papillomavirus and cervical cancer. Lancet 382, 889\u2013899 (2013).","journal-title":"Lancet"},{"key":"30514_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1158\/1055-9965.EPI-12-1406","volume":"22","author":"M Schiffman","year":"2013","unstructured":"Schiffman, M. & Wentzensen, N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol. Biomark. Prev. 22, 553\u2013560 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"30514_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","volume":"127","author":"EEL Jansen","year":"2020","unstructured":"Jansen, E. E. L. et al. Effect of organised cervical cancer screening on cervical cancer mortality in europe: A systematic review. Eur. J. Cancer. 127, 207\u2013223 (2020).","journal-title":"Eur. J. Cancer"},{"key":"30514_CR6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/diagnostics12061508","volume":"12","author":"A Macios","year":"2022","unstructured":"Macios, A. & Nowakowski, A. False negative results in cervical cancer screening\u2014Risks, reasons and implications for clinical practice and public health. Diagnostics (Basel). 12, 1508 (2022).","journal-title":"Diagnostics (Basel)"},{"key":"30514_CR7","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.12659\/MSM.895227","volume":"21","author":"MU Barut","year":"2015","unstructured":"Barut, M. U. et al. Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions. Med. Sci. Monit. 21, 3860\u20133867 (2015).","journal-title":"Med. Sci. Monit."},{"key":"30514_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3892\/ijmm.2024.5374","volume":"53","author":"M Lizano","year":"2024","unstructured":"Lizano, M., Carrillo-Garc\u00eda, A., De La Cruz-Hern\u00e1ndez, E., Castro-Mu\u00f1oz, L. J. & Contreras-Paredes, A. Promising predictive molecular biomarkers for cervical cancer (Review). Int. J. Mol. Med. 53, 50 (2024).","journal-title":"Int. J. Mol. Med."},{"key":"30514_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1159\/000499337","volume":"63","author":"G Poulet","year":"2019","unstructured":"Poulet, G., Massias, J. & Taly, V. Liquid biopsy: General concepts. Acta Cytol. 63, 449\u2013455 (2019).","journal-title":"Acta Cytol."},{"key":"30514_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","volume":"40","author":"G De Rubis","year":"2019","unstructured":"De Rubis, G., Rajeev Krishnan, S. & Bebawy, M. Liquid biopsies in cancer diagnosis, monitoring, and prognosis. Trends Pharmacol. Sci. 40, 172\u2013186 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"30514_CR11","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/cancers13163968","volume":"13","author":"P Cafforio","year":"2021","unstructured":"Cafforio, P. et al. Liquid biopsy in cervical cancer: Hopes and pitfalls. Cancers (Basel). 13, 3968 (2021).","journal-title":"Cancers (Basel)"},{"key":"30514_CR12","doi-asserted-by":"publisher","first-page":"6650966","DOI":"10.1155\/2021\/6650966","volume":"2021","author":"RL Causin","year":"2021","unstructured":"Causin, R. L. et al. MicroRNA biomarkers of high-grade cervical intraepithelial neoplasia in liquid biopsy. Biomed Res. Int. 2021, 6650966 (2021).","journal-title":"Biomed Res. Int."},{"key":"30514_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach, H., Nishida, N., Calin, G. A. & Pantel, K. Clinical relevance of circulating cell-free MicroRNAs in cancer. Nat. Rev. Clin. Oncol. 11, 145\u2013156 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"30514_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","volume-title":"MicroRNA Profiling","author":"A Vishnoi","year":"2017","unstructured":"Vishnoi, A. & Rani, S. MiRNA biogenesis and regulation of diseases: An overview. In MicroRNA Profiling (ed Rani, S.) vol 1509 1\u201310 (Springer New York, 2017)."},{"key":"30514_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/ijms17050627","volume":"17","author":"E Larrea","year":"2016","unstructured":"Larrea, E. et al. New concepts in cancer biomarkers: Circulating MiRNAs in liquid biopsies. Int. J. Mol. Sci. 17, 627 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"30514_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.20892\/j.issn.2095-3941.2020.0063","volume":"17","author":"K Trakunram","year":"2020","unstructured":"Trakunram, K. et al. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer. Cancer Biol. Med. 17, 652\u2013663 (2020).","journal-title":"Cancer Biol. Med."},{"key":"30514_CR17","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1158\/0008-5472.CAN-15-2932","volume":"76","author":"CEM Weber","year":"2016","unstructured":"Weber, C. E. M. et al. miR-339-3p is a tumor suppressor in melanoma. Cancer Res. 76, 3562\u20133571 (2016).","journal-title":"Cancer Res."},{"key":"30514_CR18","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.3892\/ol.2015.3661","volume":"10","author":"C ZHOU","year":"2015","unstructured":"ZHOU, C., LU, Y. & LI, X. miR-339-3p inhibits proliferation and metastasis of colorectal cancer. Oncol. Lett. 10, 2842\u20132848 (2015).","journal-title":"Oncol. Lett."},{"key":"30514_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jasc.2014.08.002","volume":"3","author":"J Gibson","year":"2014","unstructured":"Gibson, J., Young, S., Leng, B., Zreik, R. & Rao, A. Molecular diagnostic testing of cytology specimens: Current applications and future considerations. J. Am. Soc. Cytopathol. 3, 280\u2013294 (2014).","journal-title":"J. Am. Soc. Cytopathol."},{"key":"30514_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humrep\/deac243","volume":"38","author":"S Lamon","year":"2022","unstructured":"Lamon, S. et al. The effect of the menstrual cycle on the circulating MicroRNA pool in human plasma: A pilot study. Hum. Reprod. 38, 46\u201356 (2022).","journal-title":"Hum. Reprod."},{"key":"30514_CR21","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/1471-2407-10-542","volume":"10","author":"ZS Wu","year":"2010","unstructured":"Wu, Z. S. et al. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and May be a potential biomarker for breast cancer prognosis. BMC Cancer. 10, 542 (2010).","journal-title":"BMC Cancer"},{"key":"30514_CR22","doi-asserted-by":"publisher","first-page":"20658","DOI":"10.18632\/aging.103966","volume":"12","author":"J Feng","year":"2020","unstructured":"Feng, J. et al. Cross-talk between the ER pathway and the LncRNA MAFG-AS1\/miR-339-5p\/ CDK2 axis promotes progression of ER\u2009+\u2009breast cancer and confers Tamoxifen resistance. Aging (Albany NY). 12, 20658\u201320683 (2020).","journal-title":"Aging (Albany NY)"},{"key":"30514_CR23","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1007\/s13277-015-4390-2","volume":"37","author":"W Shan","year":"2016","unstructured":"Shan, W., Li, J., Bai, Y. & Lu, X. miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6. Tumour Biol. 37, 5203\u20135211 (2016).","journal-title":"Tumour Biol."},{"key":"30514_CR24","first-page":"2391","volume":"16","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Identification of common differentially-expressed MiRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells. Oncol. Lett. 16, 2391\u20132401 (2018).","journal-title":"Oncol. Lett."},{"key":"30514_CR25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s10147-022-02231-8","volume":"27","author":"P Gao","year":"2022","unstructured":"Gao, P., Zhao, K., Lu, W., Wang, L. & Zhang, P. miR-339-3p inhibits cell growth and epithelial-mesenchymal transition in nasopharyngeal carcinoma by modulating the KAT6A\/TRIM24 axis. Int. J. Clin. Oncol. 27, 1684\u20131697 (2022).","journal-title":"Int. J. Clin. Oncol."},{"key":"30514_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.acuro.2014.02.008","volume":"38","author":"V Medina-Villaamil","year":"2014","unstructured":"Medina-Villaamil, V. et al. Circulating MicroRNAs in blood of patients with prostate cancer. Actas Urol. Esp. 38, 633\u2013639 (2014).","journal-title":"Actas Urol. Esp."},{"key":"30514_CR27","doi-asserted-by":"publisher","first-page":"e1004712","DOI":"10.1371\/journal.ppat.1004712","volume":"11","author":"A Honegger","year":"2015","unstructured":"Honegger, A. et al. Dependence of intracellular and exosomal MicroRNAs on viral E6\/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog. 11, e1004712 (2015).","journal-title":"PLoS Pathog"},{"key":"30514_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-05408-1","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Mutant p53 in cancer: From molecular mechanism to therapeutic modulation. Cell. Death Dis. 13, 1\u201314 (2022).","journal-title":"Cell. Death Dis."},{"key":"30514_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495\u2013505 (1993).","journal-title":"Cell"},{"key":"30514_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02564-6","volume":"4","author":"H Widden","year":"2021","unstructured":"Widden, H. & Placzek, W. J. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun. Biol. 4, 1\u201312 (2021).","journal-title":"Commun. Biol."},{"key":"30514_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K Nakano","year":"2001","unstructured":"Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7, 683\u2013694 (2001).","journal-title":"Mol. Cell."},{"key":"30514_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12672-025-02744-4","volume":"16","author":"M Parvizi","year":"2025","unstructured":"Parvizi, M. et al. The role and diagnostic value of deregulated MiRNAs in cervical cancer. Discov Oncol. 16, 922 (2025).","journal-title":"Discov Oncol."},{"key":"30514_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","volume":"143","author":"K Cuschieri","year":"2018","unstructured":"Cuschieri, K. et al. Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs. Int. J. Cancer. 143, 735\u2013745 (2018).","journal-title":"Int. J. Cancer"},{"issue":"Suppl 1","key":"30514_CR34","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","volume":"76","author":"N Wentzensen","year":"2016","unstructured":"Wentzensen, N., Schiffman, M., Palmer, T. & Arbyn, M. Triage of HPV positive women in cervical cancer screening. J. Clin. Virol. 76 (Suppl 1), S49\u2013S55 (2016).","journal-title":"J. Clin. Virol."},{"key":"30514_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13148-018-0509-9","volume":"10","author":"I Babion","year":"2018","unstructured":"Babion, I. et al. Triage of high-risk HPV-positive women in population-based screening by MiRNA expression analysis in cervical scrapes; a feasibility study. Clin. Epigenetics. 10, 76 (2018).","journal-title":"Clin. Epigenetics"},{"key":"30514_CR36","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.jlb.2025.100296","volume":"8","author":"AG Cicatiello","year":"2025","unstructured":"Cicatiello, A. G. et al. Circulating MiRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis. J. Liquid Biopsy 8, 100296 (2025).","journal-title":"J. Liquid Biopsy"},{"key":"30514_CR37","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.jlb.2025.100305","volume":"9","author":"F Crocetto","year":"2025","unstructured":"Crocetto, F. et al. Blood and urine-based biomarkers in prostate cancer: current advances, clinical applications, and future directions. J. Liquid Biopsy. 9, 100305 (2025).","journal-title":"J. Liquid Biopsy"},{"key":"30514_CR38","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/JCM.03386-12","volume":"51","author":"A Rao","year":"2013","unstructured":"Rao, A. et al. Development and characterization of the Cobas human papillomavirus test. J. Clin. Microbiol. 51, 1478\u20131484 (2013).","journal-title":"J. Clin. Microbiol."},{"key":"30514_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10561-021-09941-9","volume":"23","author":"AC Neuber","year":"2022","unstructured":"Neuber, A. C. et al. The biobank of Barretos cancer hospital: 14 years of experience in cancer research. Cell. Tissue Bank. 23, 271\u2013284 (2022).","journal-title":"Cell. Tissue Bank."},{"key":"30514_CR40","unstructured":"The R Project for Statistical Computing. https:\/\/www.r-project.org\/"},{"key":"30514_CR41","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30514-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:02:33Z","timestamp":1767834153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30514"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30514-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"828"}}